U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Mogamulizumab (Poteligeo): CADTH Reimbursement Recommendation: Indication: Relapsed or refractory mycosis fungoides or Sézary syndrome after at least 1 prior systemic therapy [Internet].

Mogamulizumab (Poteligeo): CADTH Reimbursement Recommendation: Indication: Relapsed or refractory mycosis fungoides or Sézary syndrome after at least 1 prior systemic therapy [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Aug.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...